Iodine-123 β-methyl-P-iodophenyl-pentadecanoic Acid (<sup>123</sup>I-BMIPP) Myocardial Scintigraphy for Breast Cancer Patients and Possible Early Signs of Cancer-Therapeutics-Related Cardiac Dysfunction (CTRCD)

(1) Background: The mortality of breast cancer has decreased due to the advancement of cancer therapies. However, more patients are suffering from cancer-therapeutics-related cardiac dysfunction (CTRCD). Diagnostic and treatment guidelines for CTRCD have not been fully established yet. Ultrasound ca...

Full description

Bibliographic Details
Published in:Journal of Imaging
Main Authors: Yuko Harada, Kyosuke Shimada, Satoshi John Harada, Tomomi Sato, Yukino Kubota, Miyoko Yamashita
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Subjects:
breast cancer
echocardiography
<sup>123</sup>I-BMIPP
myocardial scintigraphy
chemotherapy-related cardiac dysfunction (CTRCD)
Online Access:https://www.mdpi.com/2313-433X/8/11/296

Internet

https://www.mdpi.com/2313-433X/8/11/296

Similar Items